Market open
Third Harmonic Bio, Inc./$THRD
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Third Harmonic Bio, Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.
Ticker
$THRD
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Employees
53
Website
THRD Metrics
BasicAdvanced
$232M
-
-$1.09
2.87
-
Price and volume
Market cap
$232M
Beta
2.87
52-week high
$5.20
52-week low
$3.30
Average daily volume
889K
Financial strength
Current ratio
40.869
Quick ratio
40.099
Long term debt to equity
0.824
Total debt to equity
1.125
Management effectiveness
Return on assets (TTM)
-12.86%
Return on equity (TTM)
-16.41%
Valuation
Price to book
0.81
Price to tangible book (TTM)
0.81
Price to free cash flow (TTM)
-6.215
Growth
Earnings per share change (TTM)
40.14%
3-year earnings per share growth (CAGR)
-47.01%
THRD News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Third Harmonic Bio, Inc. stock?
Third Harmonic Bio, Inc. (THRD) has a market cap of $232M as of April 25, 2025.
What is the P/E ratio for Third Harmonic Bio, Inc. stock?
The price to earnings (P/E) ratio for Third Harmonic Bio, Inc. (THRD) stock is 0 as of April 25, 2025.
Does Third Harmonic Bio, Inc. stock pay dividends?
No, Third Harmonic Bio, Inc. (THRD) stock does not pay dividends to its shareholders as of April 25, 2025.
When is the next Third Harmonic Bio, Inc. dividend payment date?
Third Harmonic Bio, Inc. (THRD) stock does not pay dividends to its shareholders.
What is the beta indicator for Third Harmonic Bio, Inc.?
Third Harmonic Bio, Inc. (THRD) has a beta rating of 2.87. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.